Oncternal Therapeutics, Inc.

NASDAQ:ONCT

8.18 (USD) • At close June 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 0.7851.494.3153.3752.425000000014.73960.61314.7313.5287.1267.5053.7821.86700000
Cost of Revenue 29.7530.1790.1691210.159002.51100001.0550.7681.290.6490.6210.7731.573000000
Gross Profit -28.9681.3114.146-8.625-7.73400-2.511000013.68459.84513.4412.8796.5056.7322.2091.86700000
Gross Profit Ratio -36.9020.880.961-2.556-3.18900100000.9280.9870.9120.9520.9130.8970.584100000
Reseach & Development Expenses 29.75332.9824.08612.54410.15929.66921.46717.22813.60720.8732.31838.88731.93828.49532.34444.25938.50833.89730.92317.9510.4689.2855.9212.6790.518
General & Administrative Expenses 12.54613.45711.5958.3737.2869.399.1888.7058.2349.47811.28110.845017.41927.74923.10513.50111.3529.8457.2113.5120000
Selling & Marketing Expenses 0.2000000000000000000000000
SG&A 12.74613.45711.5958.3737.2869.399.1888.7058.2349.47811.28110.84515.43817.41927.74923.10513.50111.3529.8457.2113.5122.4052.2251.2030.256
Other Expenses 0-1.49-4.315-3.375-2.4250.6410.2160.0460.057-0.2591.488-0.01915.43800013.50111.3529.8457.2110.3570000
Operating Expenses 42.49944.94731.36617.54215.0239.05930.65525.93321.84130.34843.59949.73247.37645.91460.09367.36452.00945.24940.76825.16114.33712.0228.1463.9620.819
Operating Income -41.714-44.947-31.366-17.542-33.108-39.059-30.655-25.933-21.841-30.348-43.599-49.732-33.69213.931-46.653-54.485-45.504-38.517-38.559-23.294-14.337-12.022-8.146-3.962-0.819
Operating Income Ratio -53.139-30.166-7.269-5.198-13.6530010.3280000-2.2860.23-3.167-4.028-6.386-5.132-10.195-12.47700000
Total Other Income Expenses Net 2.2350.7770.0330.317-1.080.6410.2168.2093.138-9.0631.488-0.0190.3981.3630.1592.7055.145-74.0271.7217.6160.1430000
Income Before Tax -39.479-44.17-31.333-17.225-34.188-38.418-30.439-17.724-18.703-39.411-42.111-49.751-33.29415.294-46.494-51.78-40.359-35.51-36.839-5.678-95.4740000
Income Before Tax Ratio -50.292-29.644-7.261-5.104-14.098007.0590000-2.2590.252-3.156-3.828-5.664-4.732-9.741-3.04100000
Income Tax Expense -41.714-0.777-0.033-0.016-18.2760.641-0.047-8.191-3.1248.702-0.384-8.821-1.438-2.936-0.238-1.5624.9-72.0260.29917.25-0.143-0.1568.063-0.15-0.069
Net Income -39.479-43.393-31.3-17.209-15.912-38.418-30.439-17.724-18.703-39.411-42.111-27.075-33.29415.294-46.256-51.78-40.359-35.51-36.839-22.348-14.194-11.866-8.063-3.812-0.75
Net Income Ratio -50.292-29.123-7.254-5.099-6.562007.0590000-2.2590.252-3.14-3.828-5.664-4.732-9.741-11.9700000
EPS -13.43-16.5-12.69-16.95-30.81-11.52-12.22-8.52-9.33-33.72-46.75-30.17-40.6327.3-88.92-99.85-80.86-79.8-99.25-68.04-128.45-107.39-72.85-34.5-6.79
EPS Diluted -13.43-16.5-12.69-16.95-30.81-11.52-12.22-8.52-8.86-33.72-46.75-30.17-40.6327.3-88.92-99.85-80.86-79.8-99.25-65.01-128.45-107.39-72.85-34.5-6.79
EBITDA -41.714-44.947-31.366-17.542-14.832-39.013-30.655-34.096-24.922-21.544-43.599-49.732-34.0912.568-44.868-54.485-45.504-38.517-38.559-23.294-14.123-11.69-8.146-3.882-0.774
EBITDA Ratio -53.139-30.166-7.269-5.198-6.1160013.5790000-2.3130.207-3.046-4.028-6.386-5.132-10.195-12.47700000